Expression of CD44, E-cadherin, and antimetastatic protein nm23-H1 in complete hydatidiform moles

Gynecologic Oncology

Volumn 104, Issue 2, 2007, Pages 451-454

  Reynolds, E A ^a   DuBeshter, B ^a   Katzman, P ^a   Larson, K ^a   Katzel, S ^a   Glantz, C ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Cell adhesion molecules; Complete hydatidiform mole

Indexed keywords

CHORIONIC GONADOTROPIN; HERMES ANTIGEN; MOLECULAR MARKER; NUCLEOSIDE DIPHOSPHATE KINASE A; UVOMORULIN;

ADOLESCENT; ADULT; ARTICLE; CHI SQUARE TEST; CLINICAL ARTICLE; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; FISHER EXACT TEST; HUMAN; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; PATIENT INFORMATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; STAINING; TROPHOBLASTIC TUMOR;

ADOLESCENT; ADULT; ANTIGENS, CD44; CADHERINS; FEMALE; HUMANS; HYDATIDIFORM MOLE; NEOPLASM INVASIVENESS; NUCLEOSIDE-DIPHOSPHATE KINASE; PREGNANCY; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; UTERINE NEOPLASMS;

EID: 33846393272     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.08.030     Document Type: Article

References (11)

1. Berkowitz R.S., and Goldstein D.P. Gestational trophoblastic neoplasia. Practical gynecologic oncology (2000), Lippincott Williams and Wilkins, Philadelphia 615-638
2. Wolfberg A.J., Berkowitz R.S., Goldstein D.P., Feltmate C., and Lieberman E. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy. Obstet. Gynecol. 106 (2005) 548-552
3. Diagnosis and Treatment of Gestational Trophoblastic Disease. ACOG Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists; Number 53, June 2004.
4. Higashikawa K., Yokozaki H., Ue T., Taniyama K., Ishikawa T., Tarin D., et al. Evaluation of CD44 transcription variants in human digestive tract carcinomas and normal tissues. Int. J. Cancer 66 (1996) 11-17
5. Noordzij M.A., van Steenbrugge G.J., Schroder F.H., and Van der Kwast T.H. Decreased expression of CD44 in metastatic prostate cancer. Int. J. Cancer 84 (1999) 478-483
6. Becker K.F., Atkinson M.J., Reich U., Becker I., Nekarda H., Siewert J.H., et al. E-Cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res. 54 (1994) 3845-3852
7. Heimann R., Lan F., McBride R., and Hellman S. Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin. Cancer Res. 60 (2000) 289-304
8. Yoshida R., Kimura N., Harada Y., and Ohuchi N. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer. Int. J. Oncol. 18 (2001) 513-520
9. Heimann R., Ferguson D.J., and Hellman S. The relationship between nm23, angiogenesis, and the metastatic proclivity of node-negative breast cancer. Cancer Res. 58 (1998) 2766-2771
10. Zafon C., Obiols G., Castellvi J., Tallada N., Galofre P., Gemar E., et al. Nm23-H1 immunoreactivity as a prognostic factor in differentiated thyroid carcinoma. J. Clin. Endocrinol. Metab. 86 (2001) 3975-3980
11. Balaram P., Alex S., Panikkar B., and Rajalekshmi T.N. Adhesion-related proteins E-cadherin, P-cadherin, CD44, and CD44v6, and antimetastatic protein nm23-H1 in complete hydatidiform moles in relation to invasion potential. Int. J. Gynecol. Cancer 14 (2004) 532-539